Reporting of Observational Studies in Antiviral Therapy : A Case for STROBE?

Vandenbroucke J.P. The making of STROBE. Epidemiology 2007; 18: 797–799.

Glasziou P. , Vandenbroucke J.P. , Chalmers I. Assessing the quality of research. Brit Med J 2004; 328: 39–41.

Funai E.F. , Rosenbush E.J. , Lee M.J. , Del Priore G. Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest 2001; 51: 8–11.

Davey S.G. , Ebrahim S. Epidemiology – is it time to call it a day? Int J Epidemiol 2001; 30: 1–11.

Ioannidis J P. . Why most published research findings are false. PLoS Med 2005; 2: e124.

Egger M. , Schneider M. , Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998; 316: 140–145.

von Elm E. , Egger M. The scandal of poor epidemiological research. BMJ 2004; 329: 868–869.

Pocock S.J. , Collier T.J. , Dandreo K.J. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 2004; 329: 883–887.

Lee W. , Bindman J. , Ford T. Bias in psychiatric case-control studies: literature survey. Br J Psychiatry 2007; 190: 204–209.

Tooth L. , Ware R. , Bain C. , Purdie D.M. , Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol 2005; 161: 280–288.

von Elm E. , Altman D.G. , Egger M. , Pocock S.J. , Gotzsche P.C. , Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ 2007; 85: 867–872.

von Elm E. , Altman D.G. , Egger M. , Pocock S.J. , Gotzsche P.C. , Vandenbroucke J.P. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007; 4: e296.

von Elm E. , Altman D.G. , Egger M. , Pocock S.J. , Gotzsche P.C. , Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–1457.

Vandenbroucke J.P. , von Elm E. , Altman D.G. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007; 18: 805–835.

Vandenbroucke J.P. , von Elm E. , Altman D.G. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4: e297.

Vandenbroucke J.P. , von Elm E. , Altman D.G. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007; 147: W163–W194.

STROBE Statement. Strengthening the Reporting of Observational Studies in Epidemiology. (Updated 18 June 2008. Accessed 6 August 2008.) Available from www.strobe-statement.org/.

Altman D.G. , Schulz K.F. , Moher D. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663–694.

Rothwell P.M. , Bhatia M. Reporting of observational studies. BMJ 2007; 335: 783–784.

PLoS Med editors. Better reporting, better research: guidelines and guidance in PLoS Medicine. PLoS Med 2008; 5: e99.

Knottnerus A. , Tugwell P. STROBE – a checklist to strengthen the reporting of observational studies in epidemiology. J Clin Epidemiol 2008; 61: 323.

STROBE Statement. Strengthening the reporting of observational studies in epidemiology (Updated 18 June 2008. Accessed 6 August 2008.) Available from www.strobe-statement.org/Support.html.

Editors. Probing STROBE. Epidemiology 2007; 18: 789–790.

Ebrahim S. , Clarke M. STROBE: new standards for reporting observational epidemiology, a chance to improve. Int J Epidemiol 2007; 36: 946–948.

MacMahon B. , Weiss N.S. Is there a dark phase of this STROBE? Epidemiology 2007; 18: 791.

Rothman K.J. , Poole C. Some guidelines on guidelines: they should come with expiration dates. Epidemiology 2007; 18: 794–796.

Egger M. , Altman D.G. , Vandenbroucke J.P. Commentary: strengthening the reporting of observational epidemiology the STROBE statement. Int J Epidemiol 2007; 36: 948–950.

Egger M. , May M. , Chene G. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119–129.

Braitstein P. , Brinkhof M.W. , Dabis F. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367: 817–824.

Duvignac J. , Thiebaut R. CD4 natural history and informative censoring in Sub-Saharan Africa. J Acquir Immune Defic Syndr 2006; 43: 380–381.

Brinkhof M.W. , Dabis F. , Myer L. Early loss to program in HIV-infected patients starting potent antiretroviral therapy in lower-income countries. Bull World Health Organ 2008; 86: 559–567.

Altman D.G. , Simera I. , Hoey J. , Moher D. , Schulz K. EQUATOR: reporting guidelines for health research. Lancet; 371: 1149–1150.